CordenPharma names Jean-Luc Herbeaux CEO effective Oct. 1, 2026

Verifying
  • CordenPharma appointed Jean-Luc Herbeaux chief executive officer, succeeding Michael Quirmbach.
  • Oct. 1, 2026 marks Herbeaux's effective start date as chief executive officer.
  • Michael Quirmbach remains involved as a board member and senior adviser.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.